These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 19931602)
1. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret. Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Lin G; Rudd JA Toxicol Lett; 2010 Feb; 192(3):402-7. PubMed ID: 19931602 [TBL] [Abstract][Full Text] [Related]
2. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret. Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380 [TBL] [Abstract][Full Text] [Related]
3. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445 [TBL] [Abstract][Full Text] [Related]
4. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons. Wu ZZ; Chen SR; Pan HL Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970 [TBL] [Abstract][Full Text] [Related]
5. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret. Percie du Sert N; Rudd JA; Moss R; Andrews PL Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218 [TBL] [Abstract][Full Text] [Related]
6. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret. Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289 [TBL] [Abstract][Full Text] [Related]
8. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva). Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976 [TBL] [Abstract][Full Text] [Related]
9. Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat. Mills C; McMackin M; Jaffe R; Yu J; Zininberg E; Slee D; Gogas K; Bradbury M Neuroscience; 2008 Sep; 156(1):165-74. PubMed ID: 18706981 [TBL] [Abstract][Full Text] [Related]
10. Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews. Horn CC; Meyers K; Pak D; Nagy A; Apfel CC; Williams BA Physiol Behav; 2012 Jun; 106(4):562-8. PubMed ID: 22504494 [TBL] [Abstract][Full Text] [Related]
11. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869. Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced emesis in the Ferret: a new animal model. Florczyk AP; Schurig JE; Bradner WT Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011 [TBL] [Abstract][Full Text] [Related]
13. [Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]. Akasaka Y; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Ikeda M; Ohta J; Suminaga M Gan To Kagaku Ryoho; 1992 Aug; 19(9):1359-74. PubMed ID: 1386977 [TBL] [Abstract][Full Text] [Related]
14. The involvement of TRPV1 in emesis and anti-emesis. Rudd JA; Nalivaiko E; Matsuki N; Wan C; Andrews PL Temperature (Austin); 2015; 2(2):258-76. PubMed ID: 27227028 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Liu YL; Malik NM; Sanger GJ; Andrews PL Cancer Chemother Pharmacol; 2006 Sep; 58(3):326-33. PubMed ID: 16435157 [TBL] [Abstract][Full Text] [Related]
16. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Lu Z; Ngan MP; Liu JYH; Yang L; Tu L; Chan SW; Giuliano C; Lovati E; Pietra C; Rudd JA Physiol Behav; 2024 Oct; 284():114644. PubMed ID: 39043357 [TBL] [Abstract][Full Text] [Related]
17. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin]. Tanimura S; Banba J; Tomoyasu H; Masaki M Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]
19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
20. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret. Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]